Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nevus, Pigmented | 2 | 2017 | 222 | 0.600 |
Why?
|
Skin Diseases | 2 | 2018 | 1094 | 0.580 |
Why?
|
Skin Diseases, Infectious | 1 | 2017 | 76 | 0.560 |
Why?
|
Angiofibroma | 1 | 2016 | 55 | 0.520 |
Why?
|
Art | 1 | 2016 | 64 | 0.520 |
Why?
|
Facial Neoplasms | 1 | 2016 | 125 | 0.500 |
Why?
|
Dermatitis, Phototoxic | 1 | 2014 | 17 | 0.490 |
Why?
|
Skin Neoplasms | 4 | 2017 | 5812 | 0.430 |
Why?
|
Nails | 1 | 2014 | 296 | 0.410 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2018 | 5672 | 0.390 |
Why?
|
Transplantation Conditioning | 2 | 2016 | 1590 | 0.370 |
Why?
|
Edema | 1 | 2014 | 765 | 0.350 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 557 | 0.340 |
Why?
|
Eosinophilia | 1 | 2014 | 559 | 0.340 |
Why?
|
Antifungal Agents | 1 | 2014 | 753 | 0.330 |
Why?
|
Dermatology | 2 | 2017 | 918 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4020 | 0.330 |
Why?
|
Outpatients | 1 | 2017 | 1596 | 0.320 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1051 | 0.320 |
Why?
|
Graft vs Host Disease | 3 | 2017 | 3028 | 0.310 |
Why?
|
Tuberous Sclerosis | 1 | 2016 | 1030 | 0.300 |
Why?
|
Referral and Consultation | 1 | 2017 | 3599 | 0.230 |
Why?
|
Caregivers | 1 | 2016 | 2241 | 0.230 |
Why?
|
Curriculum | 1 | 2016 | 3738 | 0.210 |
Why?
|
Quality Improvement | 1 | 2017 | 3797 | 0.200 |
Why?
|
Clinical Competence | 1 | 2016 | 4789 | 0.180 |
Why?
|
Immunocompromised Host | 2 | 2015 | 858 | 0.170 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5430 | 0.160 |
Why?
|
Nail Diseases | 1 | 2018 | 55 | 0.150 |
Why?
|
Hospitals, Pediatric | 2 | 2017 | 1859 | 0.140 |
Why?
|
Vitiligo | 1 | 2018 | 96 | 0.140 |
Why?
|
Child | 8 | 2018 | 80079 | 0.130 |
Why?
|
Adolescent | 8 | 2018 | 88234 | 0.130 |
Why?
|
Disease Management | 2 | 2017 | 2506 | 0.130 |
Why?
|
Internship and Residency | 1 | 2016 | 5878 | 0.130 |
Why?
|
Child, Preschool | 6 | 2018 | 42188 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2018 | 26049 | 0.120 |
Why?
|
Sickness Impact Profile | 1 | 2016 | 299 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13347 | 0.120 |
Why?
|
Observation | 1 | 2016 | 310 | 0.120 |
Why?
|
Alopecia | 1 | 2018 | 412 | 0.110 |
Why?
|
Boston | 2 | 2016 | 9313 | 0.100 |
Why?
|
Infant | 4 | 2018 | 36152 | 0.100 |
Why?
|
Mycoses | 1 | 2014 | 386 | 0.090 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 463 | 0.090 |
Why?
|
Neoplasms | 2 | 2017 | 22131 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18381 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2849 | 0.090 |
Why?
|
Risk Factors | 5 | 2018 | 74115 | 0.090 |
Why?
|
Psoriasis | 1 | 2018 | 944 | 0.080 |
Why?
|
Male | 10 | 2018 | 360358 | 0.080 |
Why?
|
Radiotherapy | 1 | 2015 | 1497 | 0.080 |
Why?
|
Causality | 1 | 2014 | 1240 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2017 | 80566 | 0.080 |
Why?
|
Female | 10 | 2018 | 392148 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2017 | 2768 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2014 | 4804 | 0.060 |
Why?
|
Cystic Fibrosis | 1 | 2014 | 1285 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2372 | 0.060 |
Why?
|
Cohort Studies | 2 | 2018 | 41457 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8618 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12043 | 0.050 |
Why?
|
Humans | 10 | 2018 | 760617 | 0.050 |
Why?
|
Pediatrics | 1 | 2017 | 3588 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7960 | 0.050 |
Why?
|
Young Adult | 2 | 2018 | 59179 | 0.040 |
Why?
|
Comorbidity | 1 | 2014 | 10505 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 64568 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2014 | 22148 | 0.030 |
Why?
|
Prognosis | 1 | 2017 | 29600 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21337 | 0.030 |
Why?
|
Time Factors | 1 | 2018 | 39913 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9998 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23972 | 0.030 |
Why?
|
Advisory Committees | 1 | 2016 | 787 | 0.020 |
Why?
|
Adult | 2 | 2018 | 220969 | 0.020 |
Why?
|
Chronic Disease | 1 | 2016 | 9311 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15689 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7389 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5697 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26180 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39063 | 0.010 |
Why?
|
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_